[LXRX] YoY Quarter Result on 30-Sep-2012 [#Q3]

Stock
[LXRX] Lexicon Pharmaceuticals, Inc.
Announcement Date
07-Nov-2012
Financial Year
2012
Quarter
30-Sep-2012 [#Q3]
Profit Trend
QoQ- -13.91%
YoY- -13.16%
Quarter Report
LXRX's Result
LXRX's Financial Summary
View:
Show?
Quarter Result
30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 CAGR
Revenue 566 419 238 372 355 781 2,131 -19.81%
PBT -35,282 -40,498 -31,658 -29,539 -26,103 -27,539 -22,770 7.56%
Tax 1,627 205 503 -576 560 -26 -102 -
NP -35,282 -40,498 -31,658 -29,539 -26,103 -27,513 -19,142 10.72%
Tax Rate - - - - - - - -
Total Cost 35,848 40,917 31,896 29,911 26,458 28,294 21,273 9.08%
Ratio Analysis
30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 CAGR
NP Margin -6,233.57 -9,665.39 -13,301.68 -7,940.59 -7,352.96 -3,522.79 -898.26 38.08%
Per Share
30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 CAGR
EPS -0.34 -0.55 -0.43 -0.42 -0.54 -0.57 -0.98 -16.16%
EPS Diluted -0.34 -0.55 -0.43 -0.42 -0.54 -0.57 -0.98 -16.16%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.